ESSA Pharma Inc
NASDAQ:EPIX

Watchlist Manager
ESSA Pharma Inc Logo
ESSA Pharma Inc
NASDAQ:EPIX
Watchlist
Price: 1.61 USD -1.23%
Market Cap: 71.5m USD
Have any thoughts about
ESSA Pharma Inc?
Write Note

ESSA Pharma Inc
PP&E Net

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

ESSA Pharma Inc
PP&E Net Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company PP&E Net CAGR 3Y CAGR 5Y CAGR 10Y
ESSA Pharma Inc
NASDAQ:EPIX
PP&E Net
$295.5k
CAGR 3-Years
-1%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
B
Bright Minds Biosciences Inc
CNSX:DRUG
PP&E Net
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Theratechnologies Inc
TSX:TH
PP&E Net
$788k
CAGR 3-Years
-36%
CAGR 5-Years
-6%
CAGR 10-Years
15%
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
PP&E Net
$103.5m
CAGR 3-Years
117%
CAGR 5-Years
204%
CAGR 10-Years
100%
Covalon Technologies Ltd
XTSX:COV
PP&E Net
CA$1.4m
CAGR 3-Years
-29%
CAGR 5-Years
-8%
CAGR 10-Years
11%
Spectral Medical Inc
TSX:EDT
PP&E Net
CA$743k
CAGR 3-Years
-12%
CAGR 5-Years
-7%
CAGR 10-Years
4%
No Stocks Found

ESSA Pharma Inc
Glance View

Market Cap
71.5m USD
Industry
Biotechnology

ESSA Pharma, Inc. is a clinical stage pharmaceutical company. The company is headquartered in Vancouver, British Columbia and currently employs 30 full-time employees. The firm is focused on developing therapies for the treatment of prostate cancer. The Company’s lead candidate, EPI-7386 is an oral, small molecule that inhibits the androgen receptor (AR) through a novel mechanism of action (N-terminal domain inhibition). The firm is evaluating EPI-7386 as a monotherapy for the treatment of adult male patients with metastatic castration-resistant prostate cancer (mCRPC) resistant to standard-of-care treatments.

EPIX Intrinsic Value
8.8 USD
Undervaluation 82%
Intrinsic Value
Price

See Also

What is ESSA Pharma Inc's PP&E Net?
PP&E Net
295.5k USD

Based on the financial report for Sep 30, 2024, ESSA Pharma Inc's PP&E Net amounts to 295.5k USD.

What is ESSA Pharma Inc's PP&E Net growth rate?
PP&E Net CAGR 3Y
-1%

Over the last year, the PP&E Net growth was 334%. The average annual PP&E Net growth rates for ESSA Pharma Inc have been -1% over the past three years .

Back to Top